EP4312924A1 - Produit de soin de plaie doté d'une technologie de capteurs intégrée pour déterminer des données de la plaie - Google Patents

Produit de soin de plaie doté d'une technologie de capteurs intégrée pour déterminer des données de la plaie

Info

Publication number
EP4312924A1
EP4312924A1 EP21848157.0A EP21848157A EP4312924A1 EP 4312924 A1 EP4312924 A1 EP 4312924A1 EP 21848157 A EP21848157 A EP 21848157A EP 4312924 A1 EP4312924 A1 EP 4312924A1
Authority
EP
European Patent Office
Prior art keywords
foam
wound
sensor
layer
textile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21848157.0A
Other languages
German (de)
English (en)
Inventor
Marcin Meyer
Johanna Katharina PLENKMANN
Sina Borczyk
Kai SCHROVENWEVER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOB GmbH
Original Assignee
KOB GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOB GmbH filed Critical KOB GmbH
Publication of EP4312924A1 publication Critical patent/EP4312924A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00544—Plasters form or structure
    • A61F2013/00604—Multilayer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/0094—Plasters containing means for sensing physical parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/0094—Plasters containing means for sensing physical parameters
    • A61F2013/00944—Plasters containing means for sensing physical parameters humidity; moisture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/0094—Plasters containing means for sensing physical parameters
    • A61F2013/00948—Ph, e.g. acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/0094—Plasters containing means for sensing physical parameters
    • A61F2013/00953—Plasters containing means for sensing physical parameters temperature

Definitions

  • the invention relates to a wound dressing in which sensors for recording wound data such as pH value, moisture and temperature as well as data on the condition of the wound dressing itself can be integrated.
  • the wound dressing comprises a cover layer, at least one layer containing foam, a wound contact layer and at least one textile-based sheet product in which at least one sensor is contained.
  • Such a wound dressing can be used for chronic wounds, for example.
  • the at least one sensor can be used to continuously record information in the form of sensor data both about the condition of the wound and about the condition of the wound dressing itself.
  • the healing of skin wounds is based on the skin's ability to regenerate epithelial, connective and supporting tissue.
  • the regeneration itself is characterized by a complex process of overlapping cell activities that advance the healing process step by step.
  • phase 1 the inflammatory or exudative phase for hemostasis and wound cleansing
  • phase 2 the proliferative phase for building up granulation tissue
  • phase 3 epithelization phase
  • a wound is understood as the separation of the connection between tissues of the body shell in humans or animals. It can be associated with a loss of substance.
  • a type of wound that is particularly difficult to treat are chronic wounds, which are characterized, among other things, by the fact that they do not heal, or only very slightly, even after a treatment period of eight to ten weeks demonstrate. Consequently, it can happen that the treatment time for such wounds lasts for months. The corresponding change of bandages can cause pain in the patient over a long period of time. Due to the severe reduction in quality of life that this causes, the physical suffering is often accompanied by mental suffering, which can lead to stress for the patient.
  • Monitoring the wound beds of chronic wounds and the condition of the wound dressing can be helpful for improved treatment, especially of long-term patients, since this increases treatment safety and avoids frequent dressing changes. By continuously recording wound parameters, such monitoring can also offer the opportunity to conduct more intensive research into wound healing processes.
  • Monitoring based on the use of electronic components with rigid housings as sensors can result in these housings exerting point pressure on the wound under load, which can lead to pain in the patient.
  • the use of conventional flexible sensors does not always provide sufficient resolution rates, so that reliable measurement results can often not be obtained.
  • WO 2017/195038 A1 describes a wound dressing that contains at least one essentially flexible substrate, with this substrate carrying one or more sensors.
  • a wound dressing is described, into which a film-based substrate can be integrated, on the surface of which at least one sensor for monitoring wound data is printed/mounted.
  • Such a wound dressing appears to be in need of improvement with regard to the possibility of absorption and the attachment of the sensors.
  • the object of the present invention is to overcome the disadvantages of the prior art and to further improve the treatment of wounds, in particular of chronic wounds.
  • the present invention Advantageously influence wound healing in the epithelization or regeneration phase, so that, for example, a shorter treatment duration and/or less scarring can be achieved.
  • the aim of the present invention is to provide a wound care product which enables treatment to be as effective as possible.
  • the treatment should not be perceived as unpleasant by the patient, so that a high level of patient compliance (following the therapy instructions by the patient) is achieved. Pain during a dressing change should be reduced to the absolute minimum.
  • the wound care product should be able to be used advantageously.
  • the tasks could unexpectedly be solved by a multi-layered (multi-layered) wound care product with specially integrated sensors for recording wound parameters and the condition of the wound care product itself. Furthermore, due to the structure of the wound care product according to the invention, the data or information determined by the sensors can be recorded in a minimally invasive manner.
  • One subject of the invention is therefore a wound dressing comprising:
  • the new wound dressing according to the invention is characterized by several unexpected advantages.
  • the at least one sensor is contained in the at least one textile-based sheetlike product, the at least one sensor is less susceptible to faults, for example when pressure is exerted from the side facing away from the wound. Furthermore, the inventive arrangement of at least one Textile-based fabric, in which at least one sensor is contained, achieves a high measurement accuracy of the data determined.
  • both the condition of the wound and of the layer containing foam can be inspected and controlled at any time with little effort, without the wound dressing having to be removed from the wound for this purpose.
  • the number of wound dressing changes can be reduced to the necessary minimum, which advantageously reduces the trauma in the patient that often accompanies such a change.
  • This also increases patient compliance.
  • a sensor-based control of the "condition of the wound” includes, for example, measuring the temperature of the wound, since inflamed wounds typically have an elevated temperature.
  • the pH value of the wound exudate or the amount of wound exudate released from the wound can also be used, for example.
  • the “state of the layer containing foam” is understood to mean, for example, the amount of liquid contained in the wound dressing or its pH value.
  • the wound dressing according to the invention comprises a covering layer (a) for closing the wound space.
  • a wound space is understood to mean the wound and, if appropriate, the adjacent wound environment.
  • the covering layer is a foil.
  • the material of the covering layer is preferably a water-insoluble polymer or a metal. In a preferred embodiment of the invention, the material of the covering layer is a water-insoluble polymer.
  • the water-insoluble polymer preferably has a solubility in EEO of 10 mg/l or less, more preferably 1 mg/ml or less, in particular 0.0001 to 1 mg/ml (determined using the column elution method according to EU guideline RL67-548- EEC, Annex V Chapter A6).
  • EEO solubility in EEO
  • examples are polyurethane, polyether urethane, polyester urethane, polyester, polypropylene, polyethylene, polyamide or polyvinyl chloride, polyorganosiloxane (silicone), polyether-polyamide copolymers, polyacrylate or polymethacrylate or a mixture thereof.
  • a foil made of a liquid-impermeable and water-vapor-permeable polymer film is preferably suitable as cover layer (a).
  • cover layer (a) examples are polymer films made from polyester, polyurethane, polyether urethane, polyester urethane, polyether polyamide copolymers, polyacrylate or polymethacrylate.
  • a polyester, polyurethane, polyester urethane or polyether urethane film is particularly preferred as the covering layer.
  • the water vapor permeability of the polymer film is preferably at least 300 g/m 2 /24 hours, in particular at least 1000 g/m 2 /24 hours and very particularly preferably at least 2000 g/m 2 /24 hours up to, for example, 5000 g/m 2 / 24 hours or 10,000 g/m 2 /24 hours (measured according to DIN EN 13726, upright).
  • the cover layer comprises a textile-based sheet product.
  • Textile-based fabrics include, regardless of the manufacturing technique, the different fabrics such as woven, knitted, non-woven and braided fabrics.
  • Fabric can be understood to mean weaving products. These include, for example, cloth, velvet and other fabrics made from special thread arrangements, which are essentially perpendicular to one another.
  • the longitudinal threads are called warp threads and the transverse threads are called weft threads. In order to achieve sufficient fabric strength, the warp and weft threads must be tightly woven together and therefore have a closed appearance.
  • Knitted fabrics are also known under the term knitted fabrics or warp-knitted goods. Knitted fabrics are knitted goods and are fabrics that are mostly machine-made from thread systems through stitch formation.
  • a knitted fabric is a textile mesh structure made from yarn(s) by looping threads, whereby the stitches in a row are formed one after the other.
  • a non-woven fabric is to be understood as meaning a surface or three-dimensional structure made of fibers which are arranged in a direction or are located randomly relative to one another and which have been mechanically and/or thermally and/or chemically bonded.
  • Non-woven fabrics are essentially different from woven, braided, and crocheted fabrics.
  • a braid is a product made by twisting multiple strands of yarn together.
  • the fibers and/or filaments, which are further processed into textile fabrics as yarn or twine can be of natural or synthetic origin or contain mixtures thereof.
  • Fibers of natural origin include, for example, silk, viscose, cotton and wool.
  • Fibers and/or filaments of synthetic origin include synthetic polymers (artificial fibres) such as polyacrylates, polyamides, polyimides, polyamideimides, polyurethanes, polyesters (particularly polyethylene terephthalate and polybutylene terephthalate), polyether esters, polyethers, polyacrylonitriles, polyalkenes (particularly polyethylenes and polypropylenes) and polytetrafluoroethylene.
  • the cover layer preferably has a thickness of 15 to 60 gm, in particular 20 to 40 gm and very particularly preferably 25 to 30 gm.
  • the covering layer (a) can be covered with an adhesive layer (k).
  • the covering layer has a moisture-proof, water vapor-permeable and adhesive edge section. This edge section ensures that the wound dressing can be applied and fixed at its intended location. In addition, it is ensured that no liquid can escape between the covering layer and the skin surrounding the wound to be treated.
  • Particularly preferred adhesives are those which, in a thin application of 20 to 35 g/m 2 together with the film, have a water vapor permeability of 400 to 10,000 g/m 2 /24 hours and preferably 1000 to 5000 g/m 2/24 hours (measured according to DIN EN 13726, upright).
  • the wound dressing according to the invention comprises at least one foam-containing layer (b).
  • the wound dressing according to the invention comprises a foam-containing layer.
  • the wound dressing according to the invention comprises two foam-containing layers.
  • Foams are usually understood to mean materials with cells (open, closed or both) distributed over the entire mass. Such materials usually have a raw density (according to DIN EN ISO 845) that is lower than the density of the framework substance. Essentially all plastics/polymers that can be foamed are suitable for the production of foams. Examples of this are polyurethane foams, silicone foams or polystyrene (Styrofoam) foam.
  • the foam is an absorbent foam.
  • an absorbent foam will understood as a foam that can absorb a liquid such as wound exudate in its polymer matrix and/or its pores and retain (absorb) it there.
  • Open-cell foams are preferably used as foams. This can prevent, for example, wound exudate and thus the harmful/toxic substances contained therein from getting back into the wound.
  • Foams which have a high absorption capacity are preferably used. This absorption capacity should be present even if the foam has already absorbed a proportion of its own weight in water into its polymer matrix.
  • a foam can preferably have a water content of at least 10% by weight and at most 80% by weight water and a free absorption A2 of at least 10 g/g, in particular at least 12 g/g and very particularly preferably at least 15 g/g with the free absorption A2 being determined in accordance with DIN-EN 13726-1 (2002).
  • the free absorption A2 is the free absorption of the water-containing foam.
  • the cell count is preferably determined microscopically.
  • the foam can have a retention value R of at least 20%, preferably at least 30%, in particular at least 40% and very particularly preferably at least 50%.
  • the foam has a retention value R of at most 90%, in particular of at most 80% and very particularly of at most 70%.
  • the retention value R is determined according to the following method.
  • the retention value R describes the amount of water that a foam can hold to retain its matrix to the maximum, disregarding the water that could be absorbed into the pores.
  • the retention value is determined by punching out a 5 cm ⁇ 5 cm test piece (stored under standard climatic conditions) from a foam with a maximum thickness of 5 mm and measuring its weight under standard climatic conditions. The test piece is then subjected to free absorption with liquid, in particular water, analogous to DIN EN 13726-1. The amount of liquid absorbed by the pores is squeezed out of the sample using a roller (weight 5000 g, diameter 10 cm, width 5 cm) by placing the sample between fresh tissues and rolling the roller over it several times. This process is repeated until no more liquid absorption can be seen in the cellulose tissues.
  • the proportion of liquid W ww contained in the polyurethane foam after absorption and squeezing out is measured in accordance with DIN EN 14079 and calculated as follows
  • W ww the weight of liquid (water) contained in the polyurethane foam after absorption and squeezing
  • W tt the weight of the sample after drying
  • W gg the weight of the sample after absorption and after squeezing.
  • the retention value R of the foam can be at least 20%, preferably at least 30%, in particular at least 40% and very particularly preferably at least 50%.
  • the foam has a retention value R of at most 90%, in particular of at most 80% and very particularly of at most 70%.
  • the foam is furthermore preferably a hydrophilic foam.
  • the foam is selected from polyurethane foams and polysiloxane foams.
  • Polyurethane foams are particularly preferred.
  • a foam is referred to as polyurethane foam whose polymer matrix is essentially made up of polyurethane.
  • hydrophilic, open-cell polyurethane foam is particularly preferred.
  • Further preferred hydrophilic polyurethane foams have a density (also referred to as density in the case of foams) of less than 150 kg/m 3 , in particular less than 100 kg/m 3 and very particularly preferably from 10 to 90 kg/m 3 .
  • foams that can be used are polyurethane foams that can be obtained by reacting a curable mixture comprising the components
  • isocyanates Generally known aliphatic, cycloaliphatic and/or, in particular, aromatic polyisocyanates can be used as isocyanates (i).
  • Diphenylmethane diisocyanate (MDI), in particular 4,4'-diphenylmethane diisocyanate (4,4'-MDI), mixtures of monomeric diphenylmethane diisocyanates and polynuclear homologues of diphenylmethane diisocyanate (polymer MDI), tetramethylene diisocyanate (TMDI) are suitable for the production of polyurethanes.
  • hexamethylene diisocyanate (HDI) toluylene diisocyanate (TDI) or mixtures thereof.
  • MDI in particular 4,4′-MDI and/or HDI
  • the 4,4'-MDI used with particular preference can contain small amounts, up to about 10% by weight, of allophanate- or uretonimine-modified polyisocyanates. Small amounts of polyphenylene polymethylene polyisocyanate (PMDI) can also be used. The total amount of these PMDI should not exceed 5% by weight of the isocyanate used.
  • PMDI polyphenylene polymethylene polyisocyanate
  • the polyisocyanate component (i) is preferably used in the form of polyisocyanate prepolymers.
  • These polyisocyanate prepolymers can be obtained by reacting the polyisocyanates (i) described above, for example at temperatures of from 30 to 100° C., preferably at about 80° C., with a deficiency of the polyols (ii) described below to form the prepolymer.
  • the polyol/polyisocyanate ratio is chosen here such that the NCO content of the prepolymer is 8 to 28% by weight, preferably 14 to 26% by weight, particularly preferably 17 to 23% by weight.
  • Polyols such as polyether oils and/or polyester oils are typically used as compounds (ii) which are reactive toward isocyanates.
  • Polyether polyalcohols with an OH functionality of 1.9 to 8.0, a hydroxyl number of 50 to 1000 mg KOH/g and optionally 10 to 100% primary hydroxyl groups are possible.
  • Such polyether polyols are known, are commercially available and are based, for example, on starter compounds which are reacted with alkylene oxides, for example propylene oxide and/or ethylene oxide, under generally known conditions.
  • the primary hydroxyl group content can be achieved by final reaction of the polyols with ethylene oxide.
  • polyester polyols (ii) used are generally obtained by condensation of polyfunctional alcohols, preferably diols, having 2 to 12 carbon atoms, preferably 2 to 6 carbon atoms, with polyfunctional carboxylic acids having 2 to 12 carbon atoms, for example succinic acid, glutaric acid, adipic acid, phthalic acid, isophthalic acid and/or terephthalic acid and mixtures thereof.
  • dihydric and polyhydric alcohols examples include ethanediol, diethylene glycol, 1,4-butanediol, 1,5-pentanediol and/or 1,6-hexanediol and mixtures thereof.
  • the reaction conditions of carboxylic acid and alcohol are usually chosen so that the resulting polyester polyols have no free acid groups.
  • the resulting polyester polyols generally have a weight-average molecular weight (determined by means of gel permeation chromatography) of from 500 to 3000 g/mol, preferably from more than 1000 g/mol to 2500 g/mol.
  • the polyester polyols used have an average theoretical functionality of from 2.0 to 4, preferably from more than 2 to less than 3.
  • the polyester polyols used generally have an average OH number of from 20 to 200, preferably from 30 to 90.
  • the polyester polyols used have a viscosity of 150 mPa » s to 600 mPa s, preferably from 200 mPa s to 550 mPa s, more preferably from 220 mPa s to 500 mPa s, particularly preferably 250 mPa * s up to 450 mPa » s and in particular from 270 mPa » s to 350 mPa » s, measured according to DIN 53
  • the compounds (ii) can be used in a mixture with chain extenders and/or crosslinking agents.
  • the chain extenders are predominantly 2-functional alcohols with molecular weights of 60 to 499, for example ethylene glycol, propylene glycol, 1,4-butanediol, 1,5-pentanediol, dipropylene glycol and/or tripropylene glycol.
  • the crosslinking agents are compounds with molecular weights of 60 to 499 and 3 or more active H atoms, preferably amines and particularly preferably alcohols, for example glycerol, trimethylolpropane and/or pentaerythritol.
  • component (ii) contains (or consists of) 0-25% by weight, preferably 1 to 20% by weight, of chain extenders and/or crosslinking agents and 75 to 100% by weight, preferably 80 to 99% by weight of polyol(s), in particular polyester polyol(s), based on the total weight of component (ii).
  • Catalysts (iii) which can be used are customary compounds which accelerate the reaction of component (i) with component (ii).
  • tertiary amines and/or organic metal compounds, in particular tin compounds are suitable.
  • the following compounds can be used as catalysts: triethylenediamine, aminoalkyl and/or aminophenylimidazoles and/or tin(II) salts of organic carboxylic acids.
  • Catalysts are generally used in an amount of 0.1 to 5% by weight based on the weight of component (ii).
  • Generally known chemically or physically active compounds can be used as blowing agents (iv).
  • Water which forms carbon dioxide by reaction with the isocyanate groups, can preferably be used as the physically acting blowing agent.
  • physical blowing agents are (cyclo)aliphatic hydrocarbons, preferably those having 4 to 8, particularly preferably 4 to 6 and in particular 5 carbon atoms, partially halogenated hydrocarbons or ethers, ketones or acetates.
  • the amount of blowing agent used depends on the desired density of the foams.
  • the different propellants can be used individually or in any mixtures with one another. Particular preference is given to using only water as blowing agent, generally in an amount of from 0.1 to 5% by weight, in particular from 2.5 to 4% by weight, based on the weight of component (ii).
  • Physical blowing agents are preferably used in an amount of ⁇ 0.5% by weight, based on the weight of component (ii).
  • the reaction is optionally carried out in the presence of auxiliaries and / or additives (v), such as. B. fillers, cell regulators, cell openers, surface-active compounds and / or stabilizers against oxidative, thermal or microbial degradation or aging.
  • auxiliaries and / or additives such as. B. fillers, cell regulators, cell openers, surface-active compounds and / or stabilizers against oxidative, thermal or microbial degradation or aging.
  • components (i) and (ii) are generally reacted in amounts such that the equivalent ratio of NCO groups to the sum of the reactive hydrogen atoms is 1:0.8 to 1:1.25, preferably 1: 0.9 to 1:1.15.
  • a ratio of 1:1 corresponds to an NCO index of 100.
  • Polyurethane foam is generally ensured by a suitable choice of components (i) to (v) known to those skilled in the art.
  • foams which can be used are polyurethane foams which can be obtained by mechanically beating up aqueous polyurethane dispersions such as, for example, Baymedix FD 103 and Baymedix AD111 (Covestro).
  • aqueous polyurethane dispersions such as, for example, Baymedix FD 103 and Baymedix AD111 (Covestro).
  • Such foams can advantageously have high mechanical strength and good thermoformability. This makes it possible to customize the foam after it has been whipped up and cured using thermal processes or thermally with others
  • Components such as to laminate a polyurethane film.
  • the at least one foam-containing layer comprises a composite of different foams.
  • a particularly advantageous composite comprises at least one layer of a polyurethane foam which can be obtained by mechanically beating up aqueous polyurethane dispersions and at least one layer of a polyurethane foam which can be obtained by converting a curable mixture comprising the components (i) polyisocyanate,
  • blowing agents and (v) optional additives as set out above.
  • the foam that can be obtained by mechanical beating usually has larger pores and is arranged on the side of the wound.
  • the foam obtained by chemical reaction usually has finer pores and is placed on top of the larger-pored foam on the side facing away from the wound.
  • a capillary effect can be generated by this arrangement, which can additionally promote the transport of liquid from the wound.
  • any wound contact layer known from the prior art can be used as the wound contact layer (c), as long as wound exudate can pass through and the material does not tend to grow together or stick to the wound tissue. Examples of suitable wound contact layers are described in German patent applications DE 10 2008 062 472, DE 10 2008 031 183 and DE 10 2008 031 182.
  • the wound contact layer contains a hydrophobic material.
  • the wound contact layer particularly preferably contains a silicone, in particular an adhesive silicone.
  • the wound contact layer can be, for example, a silicone grid, a silicone foil or a silicone film.
  • the wound contact layer may be a grid, foil or film made from a polymeric material which has been siliconized, ie the polymeric material has been treated with silicon which is substantially bonded to the surface of the polymeric material.
  • silicone can already be added during the formation of the polymer or even take part in the production of the polymer material for the wound contact layer, so that a silicone-containing polymer material is produced.
  • the wound contact layer can be perforated, ie the wound contact layer can have perforation holes. A perforation hole can be viewed as an opening going through the wound contact layer.
  • Perforation holes can be obtained using any suitable perforating device such as nails, needles or a punch.
  • the perforation can also be carried out, for example, by punching, kiss-cutting (scoring), ultrasonic cutting or ultrasonic punching.
  • the opening of a perforation hole can have any shape.
  • the opening of a perforation hole can be rectangular, square, circular, elliptical, triangular, pentagonal, hexagonal, octagonal or diamond-shaped.
  • the opening of the perforation holes is preferably square, circular or elliptical, in particular circular.
  • the openings of the perforation holes preferably have a size of between 1.75 mm 2 and 12.5 mm 2 , more preferably between 2.0 mm 2 and 8.5 mm 2 , in particular between 2.25 mm 2 and 5.0 mm 2 .
  • the size of the perforation hole opening between 1.75 mm 2 and 12.5 mm 2 corresponds to a perforation hole diameter of about 1.5 mm to about 3.9 mm.
  • the size of the perforation hole opening between 2.25 mm 2 and 5.0 mm 2 corresponds to a perforation hole diameter of about 1.7 mm to about 2.5 mm.
  • the sum of the areas of the perforation hole openings is preferably between 10% and 50%, more preferably between 12% and 45%, in particular between 15% and 30% of the total area of the wound contact layer.
  • the sum of the areas of the perforation hole openings is preferably about 15%, about 16%, about 17%, about 18%, about 19%, about 20%, about 21%, about 22%, about 23%, about 24%, about 25%, about 26%, about 27%, about 28%, about 29% or about 30%, preferably about 25%.
  • the wound contact layer has perforation holes which have a perforation pattern such that the average peel force in the machine direction and the average peel force in the transverse direction (to) the wound contact layer is no more than 5%, preferably no more than 4%, in particular no more than 3 % differ from each other.
  • the wound contact layer preferably has perforation holes which have a perforation pattern such that the wound contact layer has an amplitude between the highest and lowest values of the peel force curve of no more than 25%, preferably no more than 15% of the average peel force.
  • the peel force is determined according to a method based on FINAT n°1 where the peel force is determined over a width of 25 mm.
  • the perforation holes in the wound contact layer are equidistant from one another to form a machine and transverse oriented square.
  • the perforation holes in the wound contact layer are arranged at the same distance from one another, so that they form a square oriented at a 45° angle to the machine and transverse directions.
  • the perforation holes in the wound contact layer are equidistant from one another to form an equilateral triangle, with the aligned holes being at an angle of between 10° and 20° to the machine and transverse directions.
  • the wound contact layer consists of a PU membrane coated on both sides, with the side facing the wound being applied with a silicone gel, while the side facing the wound foam is coated with an acrylic adhesive (Acrysil 150, from Advanced Silicone Coating SAS ).
  • the wound dressing according to the invention comprises at least one textile-based sheet product (d) which contains at least one sensor.
  • the wound dressing according to the invention comprises two textile-based fabrics that are independent of one another and each contain at least one sensor.
  • the wound dressing according to the invention comprises three textile-based fabrics that are independent of one another and each contain at least one sensor.
  • the at least one textile-based planar product, in which at least one sensor is contained can be designed as a textile-based planar structure as described above, such as a woven fabric, knitted fabric, non-woven fabric, mesh, bobbinet, tulle, net and felt.
  • the at least one textile-based sheet product, which contains at least one sensor is a knitted fabric, preferably a warp knitted fabric.
  • the at least one sensor contained in the at least one textile-based sheet product can be a sensor known to the person skilled in the art.
  • the sensor can, for example, be a sensor which is based on a thermoelectric, resistive, capacitive, inductive, optical, acoustic, magnetic, chemical or other operating principle.
  • the sensor can be in the form of an integrated circuit (“microchip”), for example.
  • the at least one sensor contained in the at least one textile fabric can be designed as an electrically conductive thread.
  • a thread is a pliable (flexible) structure that has a dominant one-dimensional extension and a uniformity in the longitudinal direction.
  • a thread also includes yarns and threads.
  • the electrically conductive thread can conduct electricity.
  • the conductive thread can preferably be configured as a conductive wire.
  • This wire can have a diameter of 10 gm to 250 gm, preferably 20 gm to 150 gm, more preferably 30 gm to 100 gm, in particular about 50 gm.
  • An electrically conductive thread is a thread that includes an electrically conductive material, in particular is coated with it, or consists of a conductive material.
  • any thread can have an electrically conductive coating, which causes the thread to be electrically conductive.
  • Conductive material means a material that can conduct electricity. Examples include metals such as silver, copper, aluminum, zinc and iron. Alternatively, alloys of metals such as brass can also be used.
  • Conductive polymers and semiconductors such as silicon as element semiconductors, GaP, ZnO, CdS, GaTe, SiC as compound semiconductors and tetracene, acridone, indanthrone and Alq3 as organic semiconductors are also suitable as material for the conductive thread(s).
  • Graphite is also suitable as a material for the conductive thread/threads.
  • a thread considered to be electrically conductive has an electrical resistance of at most 2000 ohms/m, preferably at most 1000 ohms/m, preferably at most 500 Ohm/m. This means that a piece of thread 1 m in length has an electrical resistance of at most 2000 ohms or at most 1000 ohms or at most 500 ohms in a conventional resistance measurement.
  • threads conditioned under standard laboratory conditions are used, ie threads which are dry and which have been conditioned for at least 24 hours at a temperature of 20°C and a relative humidity of 65% .
  • the conductive filament/wire is preferably insulated from the environment to provide accurate measurement data on the one hand and to prevent potentially adverse effects on wound healing due to the flow of electricity on the other.
  • the insulating materials known to those skilled in the art can be used for this purpose.
  • the at least one conductive thread is an enamelled copper wire, in particular an enamelled copper wire that is insulated with a polyurethane.
  • the at least one sensor contained in the at least one textile-based sheet product can be designed as a conductive filament.
  • Filaments are fibers with a practically unlimited length (“continuous fibres”).
  • a filament can be made by wet, dry, or melt spinning processes.
  • a filament can comprise fibers from raw materials of natural origin, such as a viscose filament.
  • a filament may comprise fibers of synthetic origin.
  • a filament produced by a melt spinning process can comprise fibers made from thermoplastics such as polyester.
  • filaments which can include fibers of both natural and synthetic origin.
  • a conductive filament also contains a conductive material, preferably a metal, a polymer or a copolymer. The conductive material can be present as a coating on a non-conductive base material.
  • the at least one sensor contained in the at least one textile fabric is arranged in an ordered structure in the textile-based fabric.
  • an ordered structure is a repeating structure with a defined
  • FIG. 1 shows a detail from FIG. 1 and a light micrograph thereof.
  • Thread/threads and/or the conductive filament(s) are generated, generated or also advantageously reduced, so that a higher accuracy of the sensor is achieved or an analog sensor signal that is less susceptible to interference can be detected.
  • the at least one textile-based planar product containing a sensor is a warp-knitted fabric, of whose thread systems at least one thread and/or filament preferably has conductive properties and can be used as a sensor.
  • the thread with a sensory function can be a PES f48 yarn manufactured by TWD Fibers GmbH, which is wrapped with two enameled copper wires from Superior ESSEX, with the at least one sensor being integrated using weft insertion technology. This can be done, for example, using a Comez 609 galloon crochet machine.
  • the at least one conductive thread (sensor thread) can be integrated into the textile-based fabric as an interweaving or as a partial weft.
  • the as At least one sensor integrated into the at least one textile-based planar product can preferably cover a larger area and thus lead to increased measurement accuracy depending on the sensor principle used.
  • the ends of the conductive thread and/or the conductive filament of the at least one sensor contained in at least one textile-based fabric are each finally led out under the cover layer and provided with a connection there, so that a device, in particular a device which has a microprocessor/microcontroller includes, can be connected to read out the parameters to be determined.
  • the at least one sensor contained in at least one textile-based fabric can measure the proportion of liquid, the temperature or the pH value.
  • the at least one sensor contained in at least one textile-based sheet product can preferably be a liquid sensor, a temperature sensor or a pH sensor.
  • the moisture of the wound can be measured with the aid of a sensor that measures the liquid. Then, for example, after a measurement that has confirmed an amount of moisture that is advantageous for wound healing, there is no need to change the bandage.
  • the amount of liquid absorbed into the foam can also be determined using the sensor described above. This is of great importance as the foam has a limited absorption capacity. Even before this absorption capacity (“filling level of the foam”) is reached, the dressing should be changed in order to continue to maintain a climate that is favorable for wound healing. Furthermore, the temperature of the wound can be measured using a temperature-measuring sensor. From the temperature obtained, conclusions can be drawn about the condition of the wound or the presence of an inflammation, and a decision can then be made as to whether a change of dressing is necessary.
  • a sensor that determines the pH value of the wound it can be determined, for example, whether an environment that promotes the growth of bacteria and biofilms is present and action can be taken accordingly, for example by changing the bandage and administering appropriate active ingredients.
  • At least one sensor can be contained in the textile-based sheet product.
  • a sensor is contained in the textile-based sheet product.
  • the sensor can be, for example, a liquid sensor as the first sensor, a temperature sensor and/or a pH sensor.
  • the textile-based sheet product can contain two identical sensors, for example two liquid sensors or two temperature sensors.
  • the textile-based sheet product can contain two different sensors, for example a liquid sensor as the first sensor and a temperature sensor or pH sensor as the second sensor.
  • the textile-based sheet product can contain three identical sensors, for example three liquid sensors or three temperature sensors.
  • the textile-based sheet product can contain different sensors, for example two liquid sensors and one temperature sensor.
  • the textile-based sheet product can contain a liquid sensor as the first sensor, a temperature sensor as the second sensor and a pH sensor as the third sensor. In this way, the temperature, the presence of liquid and/or the pH value can be measured independently of one another by the at least one sensor contained in the at least one textile-based sheet product.
  • the wound dressing comprises two foam-containing layers.
  • the two foam-containing layers comprise the same foam.
  • the two foam-containing layers preferably comprise different foams, which can be based on different polymer matrices, for example.
  • the two foam-containing layers may contain different pore size foams, with the larger pore size foam facing the wound. Such an arrangement has the advantage that the resulting capillary effects can be exploited.
  • the at least one sensor contained in at least one textile-based sheet product is between the cover layer and the foam-containing layer, in the foam-containing layer, between two foam-containing layers, between the foam-containing layer and the wound contact layer and/or in the arranged wound contact layer.
  • the at least one sensor contained in at least one textile-based planar product is arranged between the covering layer and the foam-containing layer or in the foam-containing layer, preferably in the vicinity of the covering layer.
  • the sensor is preferably a liquid sensor, with the aid of which the liquid, in particular the aqueous, Measured proportions of the foam-containing layer and from this the (still) existing absorption capacity of the foam can be determined or estimated. Based on the (residual) absorption capacity of the foam, it can be decided whether a dressing change is necessary or can be omitted.
  • the in at least one is textile-based
  • Sheet product containing at least one sensor arranged between two layers containing foam.
  • At least one of the sensors is preferably a liquid sensor, with the aid of which the aqueous/liquid fractions of the foam-containing layer facing the wound can be measured and the (still) existing absorption capacity of the foam can be determined therefrom. Based on the (residual) absorption capacity of the foam, it can be decided whether a dressing change is necessary or can be omitted.
  • the in at least one is textile-based
  • the at least one sensor is preferably a liquid sensor, with the aid of which the moisture of the wound can be measured and the condition of the wound and possible measures such as a necessary change of bandage can be inferred from this.
  • the at least one sensor contained in at least one textile-based planar product is arranged between the foam-containing layer and the wound contact layer.
  • the at least one sensor is preferably a temperature sensor, with the help of which the temperature of the wound is measured and the condition of the wound and possible
  • Measures such as a dressing change can be closed.
  • the in at least one is textile-based
  • Sheet product containing at least one sensor between foam containing layer and wound contact layer arranged.
  • the at least one sensor is preferably a pH sensor, with the aid of which the pH value of the wound can be measured and the condition of the wound and possible measures such as a dressing change can be inferred from this.
  • the at least one sensor contained in at least one textile-based sheet product is arranged between two layers containing foam.
  • the at least one sensor is preferably a pH sensor, which can be used to measure the pH value of the liquid (wound exudate) secreted by the wound and to draw conclusions about the condition of the wound and possible measures such as changing the bandage or administering active ingredients.
  • Another aspect of the invention is a method of making a wound dressing according to the invention comprising the steps
  • step (ii) arranging (a) cover layer, (b) at least one layer containing foam, (c) wound contact layer and (d) at least one textile-based sheet product, in which at least one sensor is contained, wherein the at least one textile-based sheet product, in which at least a sensor is contained between (a) cover layer and (b) at least one foam-containing layer, between two foam-containing layers (b1) and (b2) and/or (b) at least one foam-containing layer and (c) Wound contact layer or in the (c) wound contact layer is arranged.
  • step (i) (a) covering layer, (b) at least one layer containing foam, (c) wound contact layer and (d) at least one textile-based sheet product containing at least one sensor are provided.
  • step (ii) (a) cover layer, (b) at least one foam-containing layer, (c) wound contact layer and (d) at least one textile-based sheet product containing at least one sensor are arranged one on top of the other, the at least one textile-based Flat product containing at least one sensor between (a) cover layer and (b) at least one foam-containing layer, between two foam-containing layers (b1) and (b2) and/or (b) at least one foam-containing layer and (c) the wound contact layer or in the (c) wound contact layer.
  • the (d) at least one textile-based sheet product, in which at least one sensor is contained can preferably be placed between (a) cover layer and (b) foam-containing layer, in (b) foam-containing layer, between two foam-containing layers ( bl) and (b2) and/or between (b) foam-containing layer and (c) wound contact layer.
  • the wound dressing according to the invention comprises
  • the wound dressing according to the invention comprises
  • a silicone layer preferably a silicone grid, as a wound contact layer and
  • the wound dressing according to the invention comprises
  • a silicone layer preferably a silicone grid, as a wound contact layer and
  • a warp knit containing a sensor (d) a warp knit containing a sensor, the warp knit containing the sensor being sandwiched between two foam-containing layers of polyurethane foam and the two foam-containing layers and the warp knit containing the sensor is, is arranged between the silicone layer, preferably a silicone grid, and the cover layer, preferably a polyurethane film.
  • a further aspect is the use of a wound dressing according to the invention for covering a wound space for a period of one to 14 days.
  • the wound dressing can be used to cover the wound for a period of one to twelve days, one to ten days, one to eight days, one to six days, one to five days, one to four days, one to up to three days or one to two days.
  • the wound dressing can be used to cover the wound for a period of two to fourteen days, two to twelve days, two to ten days, two to eight days, two to six days, two to five days, two to four days, or two to three days.
  • the wound dressing can be used to cover the wound for a period of 3 to 14 days, 3 to 12 days, 3 to 10 days, 3 to 8 days, 3 to 6 days, 3 to 5 days or 3 to 12 days to be used for four days.
  • the sensors can be used to determine that both the wound and the bandage are in a condition that does not make it necessary to change the bandage. This can avoid unnecessary dressing changes.
  • Another aspect of the invention is a conductive thread and/or a conductive filament contained in a wound dressing according to the invention for use in the treatment of chronic wounds, the treatment comprising the determination of wound parameters.
  • Another aspect of the invention is a conductive thread and/or a conductive filament contained in a wound dressing according to the invention for use in diagnostics of the condition of chronic wounds, the diagnostics comprising determining wound parameters. It can be stated that by determining wound parameters, an unnecessary change of dressing and the resulting traumatic sensation can be avoided.
  • Another aspect of the invention is the use of a conductive thread contained in a textile-based fabric in the diagnosis of wounds, in particular chronic wounds.
  • Wound parameters can be determined by using a conductive thread contained in a textile-based fabric. Based on these determined Depending on the wound parameters, unnecessary dressing changes and the resulting traumatic sensation can be avoided or appropriate treatment measures such as dressing changes or administration of active ingredients can be ordered.
  • wound dressing according to the invention in the diagnosis of wounds, in particular chronic wounds.
  • Wound parameters can be determined by using a conductive thread contained in a textile-based fabric. Based on these determined wound parameters, unnecessary dressing changes and the resulting traumatic sensation can be avoided or appropriate treatment measures such as dressing changes or administration of active ingredients can be ordered.
  • the invention is intended to be illustrated by the following examples.
  • Example 1 Components of the wound dressing according to the invention
  • the cover layer is, for example, a 25 ⁇ m thick polyurethane film such as Platilon E1073 from Covestro.
  • the foam-containing layer is, for example, about 3 mm thick polyurethane foam, which can be obtained, for example, by reacting Baymedix FD 103 and AD111.
  • the wound contact layer is, for example, a perforated multilayer silicone layer (Acrysil 150, from Advanced Silicone Coating S.A.S.). or a silicone mesh with a thickness of 150 ⁇ m.
  • a perforated multilayer silicone layer (Acrysil 150, from Advanced Silicone Coating S.A.S.). or a silicone mesh with a thickness of 150 ⁇ m.
  • the at least one textile-based fabric containing a sensor can be produced, for example, as a warp-knitted fabric on a Comez 609 crochet machine, with the sensor being able to be integrated using weft insertion technology.
  • You can do this conductive thread can be used as a sensor and a yarn for producing the warp knit with the following parameters given as an example:
  • the conductive thread is an enameled copper wire from Superior Essex (USA) with a diameter of 50 ⁇ m, which has polyurethane insulation with a layer thickness of 0 .02 pm.
  • the yarn is a polyester yarn (TWD PES f48) from TWD Fibers GmbH (Germany).
  • FIG. 1 The sensoryarn was manufactured by the research facility DITF (German Institute for Textile Research, Denkendorf). Such a textile-based sheet product containing a sensor is shown in FIG.
  • the sensor yarn (1) shown in FIG. 1 was produced by the research facility DITF (German Institute for Textile Research, Denkendorf).
  • FIG. 2 shows a detail from FIG. 1 as well as a light micrograph thereof.
  • FIG. 3 shows a plan view of a wound dressing according to the invention, with an island shape of the wound dressing being recognizable.
  • Example 2a Figure 4 shows the cross-sectional view of a schematic structure of a wound dressing according to the invention along the line IV-IV of Figure 3.
  • the figure shows how the textile-based sheet product containing a sensor ("sensor fabric") (d) on a silicone grid, which serves as a wound contact layer (c), is arranged.
  • a polyurethane foam is positioned on the sensor fabric as a foam-containing layer (b) and a polyurethane film is arranged over it as a cover layer (a).
  • Av denotes a readout device.
  • Example 2b Figure 5 shows the cross-sectional view of a schematic structure of a wound dressing according to the invention along the line IV-IV of Figure 3.
  • the figure shows how a polyurethane foam as a foam-containing layer (b) on a silicone grid, which as a wound contact layer (c) is arranged, wherein the foam-containing layer (b) comprises a textile-based sheet product containing a sensor.
  • a polyurethane film is arranged as a covering layer (a) over the foam-containing layer (b).
  • Av denotes a readout device.
  • Example 3 Determination of the absorption capacity of a foam using a sensor contained in a textile-based sheet product 3.1 To determine the absorption capacity ("level") of two
  • FIG. 6 shows the two test foams E-4A and E-4B (above) and a schematic structure (below) thereof.
  • the capacity at maximum absorption is then determined.
  • the sample is tested for its free absorption capacity based on DIN EN 13726-1.
  • the weight value determined in the DIN after 30 minutes of free absorption in a test solution is supplemented by the associated electrical capacitance value, deviating from the standard.
  • This first test gives the maximum absorption capacity [g], which corresponds to an absorption capacity (level) of 100% and the associated electrical capacitance value.
  • the absorption curve (level curve) is determined.
  • the weight and the electrical capacitance value are dated every minute.
  • the fill level is determined from the weight value and assigned to the appropriate capacity value.
  • the corresponding diagrams are shown in FIG.
  • the electrical capacitance increases, for example, from sample E-4A (top figure) from about 70% and from sample E-4B (bottom Figure) from about 80% of the absorption capacity no longer increases sharply but stagnates. From this it can be concluded that the absorption capacity of the foam is (almost) exhausted and a change is necessary.
  • level the absorption capacity of the foam
  • the absorption capacity (filling level) of the foam (in %) and the electrical capacity of the sensor (in nF) are then determined analogously to what is described above.
  • the corresponding diagram is shown in FIG. As can be seen from the diagram, the capacity of the sensor is approaching a limit value, from which it can be concluded that the absorption capacity of the foam is (almost) exhausted and a replacement is imminent.
  • a sensor contained in a textile-based sheet product is placed between a film cover (can correspond to the covering layer) and a foam.
  • the fill level (in %) and the capacity of the sensor (in nF) are then determined in the same way as described above.
  • the corresponding diagram is shown in FIG. As can be seen from the diagram, the capacity increases more slowly from a certain filling level and approaches a limit value, from which it can be concluded that the absorption capacity of the foam is (almost) exhausted and a necessary change is pending.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

L'invention concerne un pansement dans lequel une technologie de capteurs peut être intégrée pour enregistrer des données d'une plaie, telles que la valeur de pH, l'humidité et la température, ainsi que des données relatives à l'état du pansement lui-même.
EP21848157.0A 2021-03-30 2021-12-30 Produit de soin de plaie doté d'une technologie de capteurs intégrée pour déterminer des données de la plaie Pending EP4312924A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102021108084.3A DE102021108084A1 (de) 2021-03-30 2021-03-30 Wundversorgungsprodukt mit integrierter Sensorik zur Ermittlung von Wunddaten
PCT/EP2021/087839 WO2022207142A1 (fr) 2021-03-30 2021-12-30 Produit de soin de plaie doté d'une technologie de capteurs intégrée pour déterminer des données de la plaie

Publications (1)

Publication Number Publication Date
EP4312924A1 true EP4312924A1 (fr) 2024-02-07

Family

ID=80035005

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21848157.0A Pending EP4312924A1 (fr) 2021-03-30 2021-12-30 Produit de soin de plaie doté d'une technologie de capteurs intégrée pour déterminer des données de la plaie

Country Status (5)

Country Link
US (1) US20240180751A1 (fr)
EP (1) EP4312924A1 (fr)
CN (1) CN116887794A (fr)
DE (1) DE102021108084A1 (fr)
WO (1) WO2022207142A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024108200A2 (fr) * 2022-11-20 2024-05-23 Burnam Biotech Llc Élément de couverture de plaie pour détecter et surveiller l'état d'une plaie, et son procédé d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008031183A1 (de) 2008-07-03 2010-01-07 Paul Hartmann Ag Wundauflage
DE102008031182A1 (de) 2008-07-03 2010-01-07 Paul Hartmann Ag Wundauflage mit Hydrogelmatrix
DE102008062472A1 (de) 2008-12-16 2010-06-17 Paul Hartmann Aktiengesellschaft Wundverband für die Unterdrucktherapie
AU2017264907A1 (en) 2016-05-13 2018-12-20 Smith & Nephew Plc Sensor enabled wound monitoring and therapy apparatus

Also Published As

Publication number Publication date
CN116887794A (zh) 2023-10-13
DE102021108084A1 (de) 2022-10-06
WO2022207142A1 (fr) 2022-10-06
US20240180751A1 (en) 2024-06-06

Similar Documents

Publication Publication Date Title
EP3139877B2 (fr) Pansement en mousse pour traitement sous vide
DE60119150T2 (de) Polysaccharidfasern
DE2651089C3 (de) Selbsthältendes Material für Stutzverbände
DE69323273T2 (de) Verbundstoff für Unterwäsche
EP2126166B1 (fr) Tissu non tissé à fibres disposées de manière aléatoire
EP2938310B1 (fr) Couche à effet de mèche pour produit d'incontinence
EP1361903B1 (fr) Pansement
DE102010051459A1 (de) Wundüberwachung mit textilen Messgrößenwandler-Systemen
Yin et al. Facile fabrication of sandwich structural membrane with a hydrogel nanofibrous mat as inner layer for wound dressing application
DE102012007307A1 (de) Hydrogelierende Fasern sowie Fasergebilde
WO2022207142A1 (fr) Produit de soin de plaie doté d'une technologie de capteurs intégrée pour déterminer des données de la plaie
DE60303297T2 (de) Elastischer vliesstoff
US20160206771A1 (en) Anti-microbial wound dressing and a method of producing the same
EP2546398A1 (fr) Structure textile plate
WO2007065456A1 (fr) Structure textile plane et procede pour sa fabrication ainsi que son utilisation
EP3100748B1 (fr) Pansement
WO2023222291A1 (fr) Pansement pour plaies
WO1994019178A1 (fr) Stratifie constitue d'une matiere textile et d'un film permeable a la vapeur d'eau
EP3074568B1 (fr) Fibres hydrogélifiantes et produit à base de fibres hydrogélifiant
KR102268976B1 (ko) 항균 부직포 드레싱
DE102012007919A1 (de) Doppellagiges textiles Flächengebilde mit einstellbaren, festem Lagenabstand in der Verwendung als Wundauflage
EP3378457A1 (fr) Textile capteur
EP3979963B1 (fr) Timbre transdermique
EP4359019A1 (fr) Matériel de recouvrement de plaie destiné à augmenter la concentration en no dans des plaies
WO2024032958A1 (fr) Couche de contact avec une plaie et pansement comprenant un non-tissé stérile

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230922

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)